Genomic analysis of fluoroquinolone-resistant Leclercia adecarboxylata carrying the ISKpn19-orf-qnrS1-ΔIS3-blaLAP-2 module in a synanthropic pigeon, Brazil.

OBJECTIVES: The aim of this study was to perform a genomic investigation of a multiple fluoroquinolone-resistant Leclercia adecarboxylata strain isolated from a synanthropic pigeon in São Paulo, Brazil. METHODS: Whole-genome sequencing was performed using an Illumina platform, and in silico deep analyses of the resistome were performed. Comparative phylogenomics was conducted using a global collection of publicly available genomes of L. adecarboxylata strains isolated from human and animal hosts. RESULTS: L. adecarboxylata strain P62P1 displayed resistance to human (norfloxacin, ofloxacin, ciprofloxacin, and levofloxacin) and veterinary (enrofloxacin) fluoroquinolones. This multiple quinolone-resistant profile was associated with mutations in the gyrA (S83I) and parC (S80I) genes and the presence of the qnrS gene within an ISKpn19-orf-qnrS1-ΔIS3-blaLAP-2 module, previously identified in L. adecarboxylata strains isolated from pig feed and faeces in China. Genes associated with arsenic, silver, copper, and mercury resistance were also predicted. Phylogenomic analysis revealed clustering (378-496 single nucleotide polymorphism differences) with two L. adecarboxylata strains isolated from human and fish sources in China and Portugal, respectively. CONCLUSIONS: L. adecarboxylata is a Gram-negative bacterium of the Enterobacterales order and is considered an emergent opportunistic pathogen. Since L. adecarboxylata has adapted to human and animal hosts, genomic surveillance is highly recommended, in order to identify the emergence and spread of resistant lineages and high-risk clones. In this regard, this study provides genomic data that can help clarify the role of synanthropic animals in the dissemination of clinically relevant L. adecarboxylata within a One Health context.

One health clones of multidrug-resistant Escherichia coli carried by synanthropic animals in Brazil.

WHO priority pathogens have disseminated beyond hospital settings and are now being detected in urban and wild animals worldwide. In this regard, synanthropic animals such as urban pigeons (Columba livia) and rodents (Rattus rattus, Rattus norvegicus and Mus musculus) are of interest to public health due to their role as reservoirs of pathogens that can cause severe diseases. These animals usually live in highly contaminated environments and have frequent interactions with humans, domestic animals, and food chain, becoming sentinels of anthropogenic activities. In this study, we report genomic data of Escherichia coli strains selected for ceftriaxone and ciprofloxacin resistance, isolated from pigeons and black rats. Genomic analysis revealed the occurrence of international clones belonging to ST10, ST155, ST224 and ST457, carrying a broad resistome to beta-lactams, aminoglycosides, trimethoprim/sulfamethoxazole, fluoroquinolones, tetracyclines and/or phenicols. SNP-based phylogenomic investigation confirmed clonal relatedness with high-risk lineages circulating at the human-animal-environmental interface globally. Our results confirm the dissemination of WHO priority CTX-M-positive E. coli in urban rodents and pigeons in Brazil, highlighting potential of these animals as infection sources and hotspot for dissemination of clinically relevant pathogens and their resistance genes, which is a critical issue within a One Health perspective.

Review of the distribution of Lophostoma carrikeri (Chiroptera: Phyllostomidae), with range extension to transitional vegetation zones in the southwestern Amazon

Lophostoma carrikeri has been mostly recorded within the Amazon biome. There are scarce records in the northern Brazilian Amazon, but also records outside this biome, which were neglected in literature. The aim of this study was to update and extend the distribution of L. carrikeri. Seven new localities in Brazil were provided, including the first records for the states of Rondônia and Mato Grosso, filling a large gap in the species distribution, and three additional records for the state of Pará. Our results reinforce the notion that L. carrikeri is widely distributed in the Amazon, but is also present in other biomes in Brazil, such as Caatinga, Cerrado, and transitional areas. (AU)

Filling gaps in the distribution of the white-winged vampire bat, Diaemus youngii (Phyllostomidae, Desmodontinae): new records for southern Amazonia / Preenchendo lacunas na distribuição do morcego-vampiro de asas brancas, Diaemus youngii (Phyllostomidae, Desmodontinae): novos registros para o sul da Amazônia

Bats of the subfamily Desmodontinae are the only hematophagous mammals, represented by three species. Among them, Diaemus youngii has the fewest records in Brazil, being poorly known demographically and ecologically. We report the first record of D. youngii for Mato Grosso state, in central-western Brazil, and provide additional records for the states of Rondônia and Tocantins, in northern Brazil, extending the known distribution of D. youngii in the southern Amazon region.

Os morcegos da subfamília Desmodontinae compreendem as únicas três espécies de mamíferos hematófagos. Entre elas, Diaemus youngii é a espécie com menor número de registros no Brasil, sendo pouco conhecida demográfica e ecologicamente. Nós relatamos o primeiro registro de D. youngii para o estado do Mato Grosso, no centro-oeste do Brasil, e fornecemos registros adicionais para os estados de Rondônia e Tocantins, no norte do Brasil. Os registros ampliam a distribuição conhecida de D. youngii no sul da região amazônica.

Indirect oral immunization of captive vampires, Desmodus rotundus.

A vaccinia-rabies glycoprotein recombinant virus (V-RG) vaccine was tested in hematophagous bats (Desmodus rotundus) kept in captivity. The vaccine was applied in a neutral vehicle (Vaseline) spread on the back of one or two vector bats, which were then reintroduced into their groups. Our hypothesis was that, as in the case of vampire bat control by vampiricide paste, the administration of V-RG vaccine through paste to one bat could indirectly protect other bats from the same group. Eight groups were tested. The rabies virus strain used to challenge the bats was isolated from a naturally infected hematophagous bat (Desmodus rotundus). The survival proportion after the virus challenge ranged between 42.8 and 71.4%. The results are encouraging because a significant number of bats that did not receive the vaccine survived the challenge. The vaccine was shown to be safe and immunogenic to hematophagous bats. No adverse effects to vaccinia virus were observed.